Skip to main content
Caplight Logo









Proximie

Proximie

Private
LondonHealthcare & Life Scienceshttps://proximie.com

Last Round

Series C

Jun 14, 2022

Total Funding Raised

$136M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Proximie operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Series C round in June 2022.

Proximie is a health technology company that provides a cloud-based surgical intelligence platform for real-time remote collaboration, surgical training, and data analytics in operating rooms.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Healthcare Analytics, Medical Devices, Vertical SaaS, AR/VR Experiences

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware + Subscription

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Proximie Comparables

Compare Proximie with similar companies based on industry and business-model similarity.

Proximie comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Rods&Cones
82%
Mendaera
82%
Caresyntax
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Proximie Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJun 14, 2022
Series BApr 21, 2021
Series ADec 10, 2019
Series AApr 1, 2019
SeedJul 20, 2016
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Nadine Hachach-Haram FRCS

Founder & CEO

Founding Team

Richard Carter

Chief Technology Officer

Executive Team

For institutional investors. Book with your work email.

Proximie Investors

Notable investors and investment history

Proximie investors
InvestorRounds
BDC LabsSeries B
SoftBank Investment AdvisersSeries C
Voyagers.ioSeries B
Minderoo FoundationSeries C
Maverick VenturesSeries B, Series C
F-Prime CapitalSeries C, Series B
JIMCOSeries B
Book a demo to see all 34 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2026

    Now available in over 800 facilities worldwide.

  • Jul 1, 2026

    Now available in over 500 facilities worldwide.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • attends_eventOct 23, 2026

    Proximie attends the Abu Dhabi Future Health Summit in the United Arab Emirates, where it signs a Memorandum of Understanding with Healthpoint to support data and advanced technology in surgical care.

  • is_developingOct 22, 2026

    Proximie Inc. partners with AiMed Solutions and Burjeel clinical teams to jointly develop advanced AI-powered solutions for surgical care under a four-stage co-development program that improves operating room efficiency, clinical decision-making, and connected surgical workflows in United Arab Emirates on Oct 22nd '26.

  • is_developingOct 22, 2026

    Proximie Inc. signs a 2026 MoU with Burjeel Holdings through AiMed Solutions to develop artificial intelligence-powered operating rooms in United Arab Emirates, aiming to improve surgical efficiency, clinical decision-making and patient care.

  • partners_withSep 11, 2026

    Proximie Inc. partners with Deloitte LLP, AWS, and eight NHS hospitals to launch a year-long surgical AI evaluation across 104 operating theatres, endoscopy suites, and catheterisation laboratories in the United Kingdom on Sep 9th '26, covering more than 20,000 procedures.

  • recognized_asSep 11, 2026

    AWS designates Proximie as an AI Pioneer through its Pioneers Project 2026.

Book a demo to see all news

For institutional investors. Book with your work email.

Proximie Filings

Explore SEC and related filing metadata, where available.

Proximie filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Proximie's valuation, stock price, and market status.

Is Proximie a public or private company?

Proximie is a private company.

What is the current stock price of Proximie?

Proximie is a private company, so its shares have no public market price. Caplight tracks Proximie's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Proximie worth (valuation)?

Valuation information for Proximie is not publicly available.

Can I buy Proximie stock?

Proximie shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Proximie's last funding round?

Proximie's most recent funding round was Series C on June 14, 2022.

Who are the main investors in Proximie?

Key investors in Proximie include F-Prime Capital, Advent Life Sciences, Global Ventures, BofA Securities, Morgan Stanley.

Will Proximie IPO soon?

No public IPO plans have been announced for Proximie.

How can I track Proximie secondary market activity?

Caplight tracks bids, offers, and trades in Proximie's shares on secondary markets.

Firmographic Details

HeadquartersLondon
Employee Range103
Year Founded2016
Last FundingJun 14, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?